Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial

Scott R. Goldsmith, Fahrettin Covut, Mark A. Fiala, Elizabeth Bradtke, Ayan Gasanli, Brandon Christen, Jonathan A. Pachter, Zhifu Xiang, Zahid Iqbal, Nathan Moore, Uchenna Ofoma, Bijal Parikh, Erik Dubberke, John F. DiPersio

Blood (2022) 140 (Supplement 1): 11185–11186.

https://doi.org/10.1182/blood-2022-157605

Published: 2022

Journal Articles

Early Onset of Smoldering Disease Correlates with Rapid Progression to Symptomatic Multiple Myeloma

Fahrettin Covut, Rishil Chopra, Sathya Sri Areti, James J. Driscoll, Ehsan Malek

Blood (2022) 140 (Supplement 1): 10816–10817.

https://doi.org/10.1182/blood-2022-163721

Published: 2022

Journal Articles

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Fahrettin Covut, MD, Ramsha Ahmed, MD, Christy J. Samaras, DO, Faiz Anwer, MD, Alex V. Mejia Garcia, MD, Dana E Angelini, MD, Beth M. Faiman, PhDCNP, Janice Reed, RN, Mary Ann Karam, RN, Kristen Schlueter, RN, Saveta Mathur, CNP, Kimberly Hamilton, APRN/PA, Nathaniel Rosko, PharmD, Jason Valent, MD, Jack Khouri, MD

Blood (2019) 134 (Supplement_1): 3148.

https://doi.org/10.1182/blood-2019-131400

Published: 2019

Journal Articles

Risk of Progression in Patients with Smoldering Myeloma

Fahrettin Covut, MD, Kamal Chamoun, MD, Leland Metheny, III, MD, Kirsten M Boughan, DO, James Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2019) 134 (Supplement_1): 1892.

https://doi.org/10.1182/blood-2019-127677

Published: 2019

Journal Articles

Meta-Analyses of Clinical Trials Comparing the Progression Free Survival and Adverse Events in Treated Versus Observed Patients with Smoldering and Indolent Multiple Myeloma

Fahrettin Covut, MD, Tariq Zuheir Kewan, MD, Apoorva Anandan, MD, Folashade Otegbeye, MBBChir,MPH, James Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2019) 134 (Supplement_1): 2196.

https://doi.org/10.1182/blood-2019-125954

Published: 2019

Journal Articles

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Tariq Zuheir Kewan, MD, Shafia Rahman, MBBS, Fahrettin Covut, MD, Ramsha Ahmed, MD, Seba Hasan, Yihong Zhou, MD, Alok A Khorana, MD

Blood (2019) 134 (Supplement_1): 3683.

https://doi.org/10.1182/blood-2019-131758

Published: 2019

Journal Articles

Impact of Previous Cancer Therapy on Outcome of Patients with Multiple Myeloma or Smoldering Disease

Fahrettin Covut, MD, Gayathri Ravi, MD, James Driscoll, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD

Blood (2019) 134 (Supplement_1): 3174.

https://doi.org/10.1182/blood-2019-126059

Published: 2019

Journal Articles

Outcomes Associated with Therapeutic Anticoagulation in Patients with Brain Metastasis

Shafia Rahman, MD, Fahrettin Covut, MD, Yihong Zhou, MD, Shab E Gul Rahim, MD, Sudha Amarnath, MD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 1242.

https://doi.org/10.1182/blood-2018-99-119686

Published: 2018

Journal Articles

Prognostic Impact of Morphological Cellularity in Early Assessment Bone Marrow Biopsy after 7+3 Induction in Patients with Acute Myeloid Leukemia

Fahrettin Covut, MD, Divya Gupta, MD, Raisa Pinto, MD, Nina Dambrosio, CNP, Najla H El Jurdi, MD, Masumi Ueda, MD MA, BA, Leland Metheny, MD, Brenda W. Cooper, MD, Paolo Caimi, MD, Ehsan Malek, MD, Folashade Otegbeye, MBBChir, MPH, Marcos De Lima, MD, Ben K. Tomlinson, MD

Blood (2017) 130 (Supplement 1): 1314.

https://doi.org/10.1182/blood.V130.Suppl_1.1314.1314

Published: 2017

Journal Articles

Plerixafor Overcomes Lenalidomide-Associated Stem Cell Collection Failure and Affects Collected Myeloid and Erythroid Progenitors

Talib Dosani, MD, Stanton L. Gerson, MD, Suchitra Sundaram, MBBS, Gina Hoffman, Fahrettin Covut, MD, Katharine A. Downes, MD, Robert W. Maitta, MD PhD, Marcos De Lima, MD, Ehsan Malek, MD

Blood (2017) 130 (Supplement 1): 1922.

https://doi.org/10.1182/blood.V130.Suppl_1.1922.1922

Published: 2017

Journal Articles

Reducing Gastrointestinal Toxicity Associated with Autologous Transplantation for Multiple Myeloma without Compromising Its Anti-Myeloma Effect

Ehsan Malek, MD, Richard Creger, PhD, Merle Kolk, Fahrettin Covut, MD, Richard E Champlin, MD, Brenda W. Cooper, MD, Paolo Caimi, MD, Hillard M Lazarus, MD, Vinita Gupta, MD, Anant Vatsayan, MD MBBS, Qaiser Bashir, MD MBBS, Marcos De Lima, MD, Muzaffar H. Qazilbash, MD

Blood (2017) 130 (Supplement 1): 680.

https://doi.org/10.1182/blood.V130.Suppl_1.680.680

Published: 2017

Journal Articles

Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era

Suchitra Sundaram, MBBS, Erika Moore, MD, Sabarish Ayyappan, MBBS, Fahrettin Covut, MD, Benjamin Tomlinson, MD, Richard Creger, PhD, Ehsan Malek, MD, Leland Metheny, MD, Brenda W. Cooper, MD, Hillard M Lazarus, MD, Marcos de Lima, MD, Paolo Caimi, MD

Blood (2017) 130 (Supplement 1): 2775.

https://doi.org/10.1182/blood.V130.Suppl_1.2775.2775

Published: 2017

Journal Articles

Central Nervous System Relapse in Diffuse Large B Cell Lymphoma—Predictors at Diagnosis

Sabarish Ayyappan, MBBS, Fahrettin Covut, MD, Dhivya Prabhakar, MD, Vinita Gupta, MD, Ehsan Malek, MD, Leland Metheny, MD, Ben K. Tomlinson, MD, Richard Creger, PhD, Brenda W. Cooper, MD, Hillard M Lazarus, MD, Marcos de Lima, MD, Paolo Caimi, MD

Blood (2017) 130 (Supplement 1): 2842.

https://doi.org/10.1182/blood.V130.Suppl_1.2842.2842

Published: 2017

Journal Articles

Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis

Anand Tandra, MD, Leland Metheny, MD, David Yao, MD PhD, Paolo F. Caimi, MD, Lauren Brister, CNP, Brenda Cooper, MD, Hillard M. Lazarus, MD, Ben K. Tomlinson, MD, Ehsan Malek, MD, Fahrettin Covut, MD, Raisa Pinto, MD, Marcos deLima, MD

Blood (2016) 128 (22): 5788.

https://doi.org/10.1182/blood.V128.22.5788.5788

Published: 2016

Journal Articles

Rethinking Risk-Benefit Assessment for Phase I Multiple Myeloma Trials

Ehsan Malek, MD, Caner Saygin, MD, Rebecca Ye, Byung-gyu Kim, DVM, Fahrettin Covut, MD, Marcos De Lima, MD, James J. Driscoll, MD PhD

Blood (2016) 128 (22): 1146.

https://doi.org/10.1182/blood.V128.22.1146.1146

Published: 2016

Journal Articles

Immunologic Status Evaluated By the Absolute Lymphocyte/Monocyte Ratio Provides a Powerful Prognostic Tool for Newly Diagnosed Multiple Myeloma

Ehsan Malek, MD, Talib Dosani, MD, Raisa Pinto, MD, Fahrettin Covut, MD, Hugo Akabane, MD, James J. Driscoll, MD PhD, Marcos De Lima, MD

Blood (2016) 128 (22): 1862.

https://doi.org/10.1182/blood.V128.22.1862.1862

Published: 2016

NARROW

Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial

Early Onset of Smoldering Disease Correlates with Rapid Progression to Symptomatic Multiple Myeloma

External Validation of the Impede VTE Risk Score in Newly Diagnosed Multiple Myeloma (MM) Patients

Risk of Progression in Patients with Smoldering Myeloma

Meta-Analyses of Clinical Trials Comparing the Progression Free Survival and Adverse Events in Treated Versus Observed Patients with Smoldering and Indolent Multiple Myeloma

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Impact of Previous Cancer Therapy on Outcome of Patients with Multiple Myeloma or Smoldering Disease

Outcomes Associated with Therapeutic Anticoagulation in Patients with Brain Metastasis

Prognostic Impact of Morphological Cellularity in Early Assessment Bone Marrow Biopsy after 7+3 Induction in Patients with Acute Myeloid Leukemia

Plerixafor Overcomes Lenalidomide-Associated Stem Cell Collection Failure and Affects Collected Myeloid and Erythroid Progenitors

Reducing Gastrointestinal Toxicity Associated with Autologous Transplantation for Multiple Myeloma without Compromising Its Anti-Myeloma Effect

Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era

Central Nervous System Relapse in Diffuse Large B Cell Lymphoma—Predictors at Diagnosis

Low Dose Antithymocyte Globulin (ATG) for Graft-Versus-Host Disease (GVHD) Prophylaxis

Rethinking Risk-Benefit Assessment for Phase I Multiple Myeloma Trials

Immunologic Status Evaluated By the Absolute Lymphocyte/Monocyte Ratio Provides a Powerful Prognostic Tool for Newly Diagnosed Multiple Myeloma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only